Humalog Sales Data
| Rank 42 | Current sales rank, all U.S. Pharmaceuticals. |
Last updated: February 2014 (updated quarterly).
The following data shows Humalog U.S. retail sales in Q4 2013 compared to previous quarters.
| Date Range | Sales Rank | Sales ($000) | Units (000) | ||
|---|---|---|---|---|---|
| Q4 2013 | 42 ( 1) |
$304,866 | 6.15% | 2,664 | 1.25% |
| Q3 2013 | 43 (5) |
$287,203 | 4.25% | 2,631 | -2.19% |
| Q2 2013 | 48 | $275,495 | -1.26% | 2,690 | -0.66% |
| Q1 2013 | 48 (8) |
$279,018 | 8.17% | 2,708 | 2.85% |
| Q4 2012 | 56 (2) |
$257,939 | 2.61% | 2,633 | 3.17% |
| Q3 2012 | 58 (8) |
$251,389 | 8.03% | 2,552 | 3.53% |
| Q2 2012 | 66 ( 1) |
$232,698 | -4.86% | 2,465 | -4.09% |
| Q1 2012 | 65 | $244,587 | -2.70% | 2,570 | -3.85% |
| Q4 2011 | 65 (2) |
$251,367 | 3.78% | 2,673 | 2.81% |
| Q3 2011 | 63 (4) |
$242,208 | -0.75% | 2,600 | -1.78% |
| Q2 2011 | 67 (5) |
$244,050 | 4.83% | 2,647 | 1.15% |
| Q1 2011 | 72 | $232,809 | n/a | 2,617 | n/a |
* Units refer to the number of packages sold.
Source: IMS Health (Midas). Please review our terms of use and attribution guidelines. Copyright - All rights reserved. Unauthorized use and/or duplication of this material without express written permission is strictly prohibited.
